Renal expression of α-SMA in diabetic nephropathy and the protective effects of Telmisartan

Yi chun-xia,Liao hai-qiang,Zhou yu-lu,Pei qi,Liu shi-kun
DOI: https://doi.org/10.3969/j.issn.1672-2981.2006.04.008
2006-01-01
Abstract:OBJECTIVETo observe the renal expression of αsmooth muscle actin(α-SMA) in diabetic nephropathy(DN) rats and the effects of Telmisartan as angiotersin Ⅱ type 1(AT1) receptor antagonist.METHODS Twenty-eight diabetic nephropathy Sprague-Dawley(SD) rats induced with intraperitioneal injection of streptozotocin(STZ)were randomly divided into two groups: DN rats without therapy(group D,n=14) and DN rats treated with telmisartan(group T,n=14).Fourteen SD were used as the control(group N).The urine in 24h and blood samples were collected after the treatment with Telmisartan for 12 weeks.The rats were killed and the α-SMA was determined with immunohistochermistry.RESULTS Expression of α-SMA in the nephridial tissue,the concentration of Urine protein(UPro) in 24h,and the renal function indicatrix(BUN、Ccr、UA) were significantlu higher than those in group N(P<0.01).The expression of α-SMA and UPro、BUN、Ccr、UA、BG decreased significantly after the treatment with telmisartan(P<0.01).CONELUSION The expression of α-SMA and UPro were increased significantly in the DN rats,Telmisartan have significant renal protective effects in DN rats,and Inhibition of α-SMA activation may be one of the potential mechanisms.
What problem does this paper attempt to address?